Standard BioTools Inc (NAS:LAB)
$ 1.84 0.02 (1.1%) Market Cap: 684.96 Mil Enterprise Value: 408.10 Mil PE Ratio: 0 PB Ratio: 1.40 GF Score: 50/100

Fluidigm Corp at BTIG Virtual MedTech, Digital Health, Life Sciences, and Diagnostic Tools Conference Transcript

Feb 18, 2021 / 07:00PM GMT
Release Date Price: $6.42 (+1.90%)
Sung Ji Nam
BTIG - Life Science and Diagnostic Tools Analyst

Welcome. I'm Sung Ji Nam, Tools and Diagnostics Analyst at BTIG, and it is my pleasure to introduce Fluidigm. Presenting for Fluidigm today is the CEO, Chris Linthwaite. And with that, I'm going to turn it over to Chris for some introductory remarks. Chris?

Chris Linthwaite
Fluidigm Corporation - President & CEO

Sure. Hi, Sung Ji. Thank you very much again for the invitation. Obviously, we'd all love to be in Snowbird together versus just seeing it in a virtual background. But I just really am pleased to have this opportunity to share on our performance both on the quarter Q4 just closed as well as our prospects are, what we're calling Vision 2025.

We had -- our belief, we've taken the last six months in particular both to go from zero to 2.2 million COVID tests delivered and to overnight transform a significant portion of our Company into a diagnostics platform and business.

Going forward over the next five years, we think this transcends a COVID-specific story. And we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot